Anti-cancer immunotoxins, Challenges, and Approaches

Dashtiahangar, M; Rahbarnia, L; Farajnia, S; Salmaninejad, A; Shabgah, AG; Ghasemali, S

Farajnia, S (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, POB 51656-65811, Tabriz, Iran.

CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (7): 932

Abstract

The development of recombinant immunotoxins (RITs) as a novel therapeutic strategy has made a revolution in the treatment of cancer. RITs result from ......

Full Text Link